Refresh
Company Event • 02 Nov 2021 12:00 • Latest
Location:1-8-2 Kyutaromachi Chuo-ku
Osaka-shi
Japan
Presentation of FY2021 Q2 business results to institutional investors and business analysts
Speakers
- Gyo Sagara (President, Representative Director, and Chief Executive Officer, ONO PHARMACEUTICAL CO., LTD.)
- Toshihiro Tsujinaka (Member of the Board of Directors, Senior Executive Officer / Executive Director, Corporate Strategy & Planning, ONO PHARMACEUTICAL CO., LTD.)
- Toichi Takino (Member of the Board of Directors, Senior Executive Officer, Executive Director, Discovery & Research, ONO PHARMACEUTICAL CO., LTD.)
- Kiyoaki Idemitsu (Member of the Board of Directors, Corporate Executive Officer, Executive Director of Clinical Development, ONO PHARMACEUTICAL CO., LTD.)
- Satoshi Takahagi (Executive Director, Sales and Marketing, ONO PHARMACEUTICAL CO., LTD.)
- Kazuhiro Nagahama (Director of Finance and Accounting Department, ONO PHARMACEUTICAL CO., LTD.)
- Yukio Tani (Corporate Executive Officer, Head of Corporate Communications, ONO PHARMACEUTICAL CO., LTD.)
Analysts
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Takashi Akahane (Analyst, Tokai Tokyo Research Institute Co., Ltd.)
Duration
- Presentation: 34 minutes
- Q&A: 34 minutes
Company Event • 07 Sep 2021 14:00
Location:1-8-2 Kyutaromachi Chuo-ku
Osaka-shi
Japan
R&D Briefing
Speakers
- Gyo Sagara (President, Representative Director, and Chief Executive Officer, ONO PHARMACEUTICAL CO., LTD.)
- Toichi Takino (Member of the Board of Directors, Senior Executive Officer, Executive Director, Discovery & Research, ONO PHARMACEUTICAL CO., LTD.)
- Kiyoaki Idemitsu (Member of the Board of Directors, Corporate Executive Officer, Executive Director of Clinical Development, ONO PHARMACEUTICAL CO., LTD.)
- Yukio Tani (Corporate Executive Officer, Head of Corporate Communications, ONO PHARMACEUTICAL CO., LTD.)
Analysts
- Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Tanaka (Analyst, Mizuho Securities Co., Ltd.)
- Sawada (Analyst, JPMorgan Asset Management (Japan) Limited)
Company Event • 30 Jul 2021 13:00
Location:1-8-2 Kyutaromachi Chuo-ku
Osaka-shi
Japan
Presentation of FY2021 Q1 business results to institutional investors and business analysts
Speakers
- Toshihiro Tsujinaka (Member of the Board of Directors, Executive Officer, Executive Director of Corporate Strategy & Planning, ONO PHARMACEUTICAL CO., LTD.)
- Kiyoaki Idemitsu (Corporate Executive Officer, Executive Director of Clinical Development, ONO PHARMACEUTICAL CO., LTD.)
- Hiroshi Ichikawa (Corporate Senior Executive Officer, Executive Director of Sales and Marketing, ONO PHARMACEUTICAL CO., LTD.)
- Yukio Tani (Corporate Executive Officer, Head of Corporate Communications, ONO PHARMACEUTICAL CO., LTD.)
- Satoshi Takahagi (Business Unit Director, Oncology Business Unit, Sales and Marketing, ONO PHARMACEUTICAL CO., LTD.)
- Kazuhiro Nagahama (Director of Finance and Accounting Department, ONO PHARMACEUTICAL CO., LTD.)
Duration
- Presentation: 32 minutes
- Q&A: 32 minutes
Company Event • 12 May 2021 09:45
Location:1-8-2 Kyutaromachi Chuo-ku
Osaka-shi
Japan
Financial Results Briefing for the Fiscal Year Ended March 2021
Speakers
- Gyo Sagara (President, Representative Director, and Chief Executive Officer, ONO PHARMACEUTICAL CO., LTD.)
- Toshihiro Tsujinaka (Member of the Board of Directors, Executive Officer, Executive Director of Corporate Strategy & Planning, ONO PHARMACEUTICAL CO., LTD.)
- Toichi Takino (Member of the Board of Directors, Executive Officer, Executive Director of Discovery & Research, ONO PHARMACEUTICAL CO., LTD.)
- Hiroshi Ichikawa (Corporate Senior Executive Officer, Executive Director of Sales and Marketing, ONO PHARMACEUTICAL CO., LTD.)
- Yukio Tani (Corporate Executive Officer, Head of Corporate Communications, ONO PHARMACEUTICAL CO., LTD.)
- Kiyoaki Idemitsu (Corporate Executive Officer, Executive Director of Clinical Development, ONO PHARMACEUTICAL CO., LTD.)
- Satoshi Takahagi (Business Unit Director, Oncology Business Unit, Sales and Marketing, ONO PHARMACEUTICAL CO., LTD.)
- Kazuhiro Nagahama (Director of Finance and Accounting Department, ONO PHARMACEUTICAL CO., LTD.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Tatsuyuki Arai (Analyst, BofA Securities Japan Co., Ltd.)
- Eiji Ueda (Analyst, Goldman Sachs Japan Co., Ltd.)
- Takashi Akahane (Analyst, Tokai Tokyo Research Institute Co., Ltd.)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
Company Event • 01 Feb 2021 12:45
Location:1-8-2 Kyutaromachi, Chuo-ku
Osaka-shi
Japan
Presentation of FY2020 Q3 business results to institutional investors and business analysts
Speakers
- Toshihiro Tsujinaka (Member of the Board of Directors, Executive Officer, Executive Director of Corporate Strategy & Planning, ONO PHARMACEUTICAL CO., LTD.)
- Satoshi Takahagi (Business Unit Director, Oncology Business Unit, Sales and Marketing, ONO PHARMACEUTICAL CO., LTD.)
- Kazuhiro Nagahama (Director of Finance and Accounting Department, ONO PHARMACEUTICAL CO., LTD.)
- Hiroshi Ichikawa (Corporate Senior Executive Officer, Executive Director of Sales and Marketing, ONO PHARMACEUTICAL CO., LTD.)
- Kiyoaki Idemitsu (Corporate Executive Officer, Executive Director of Clinical Development, ONO PHARMACEUTICAL CO., LTD.)
- Yukio Tani (Corporate Executive Officer, Head of Corporate Communications, ONO PHARMACEUTICAL CO., LTD.)